These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 16146636)
1. Inhibition of Shc/Grb2 protein-protein interaction suppresses growth of B104-1-1 tumors xenografted in nude mice. Kim HK; Jeong MJ; Kong MY; Han MY; Son KH; Kim HM; Hong SH; Kwon BM Life Sci; 2005 Dec; 78(3):321-8. PubMed ID: 16146636 [TBL] [Abstract][Full Text] [Related]
2. Actinomycin D as a novel SH2 domain ligand inhibits Shc/Grb2 interaction in B104-1-1 (neu*-transformed NIH3T3) and SAA (hEGFR-overexpressed NIH3T3) cells. Kim HK; Nam JY; Han MY; Lee EK; Choi JD; Bok SH; Kwon BM FEBS Lett; 1999 Jun; 453(1-2):174-8. PubMed ID: 10403397 [TBL] [Abstract][Full Text] [Related]
3. Investigation of cell cycle arrest effects of actinomycin D at G1 phase using proteomic methods in B104-1-1 cells. Kim HK; Kong MY; Jeong MJ; Han DC; Choi JD; Kim HY; Yoon KS; Kim JM; Son KH; Kwon BM Int J Biochem Cell Biol; 2005 Sep; 37(9):1921-9. PubMed ID: 15964235 [TBL] [Abstract][Full Text] [Related]
4. Mechanism of SHIP-mediated inhibition of insulin- and platelet-derived growth factor-stimulated mitogen-activated protein kinase activity in 3T3-L1 adipocytes. Sharma PM; Son HS; Ugi S; Ricketts W; Olefsky JM Mol Endocrinol; 2005 Feb; 19(2):421-30. PubMed ID: 15486046 [TBL] [Abstract][Full Text] [Related]
5. Natural and synthetic analogues of actinomycin D as Grb2-SH2 domain blockers. Kim HK; Nam JY; Han MY; Son KH; Choi JD; Kwon BM; Takusagawa HL; Huang Y; Takusagawa F Bioorg Med Chem Lett; 2000 Jul; 10(13):1455-7. PubMed ID: 10888331 [TBL] [Abstract][Full Text] [Related]
6. Grb2 and Shc adapter proteins play distinct roles in Neu (ErbB-2)-induced mammary tumorigenesis: implications for human breast cancer. Dankort D; Maslikowski B; Warner N; Kanno N; Kim H; Wang Z; Moran MF; Oshima RG; Cardiff RD; Muller WJ Mol Cell Biol; 2001 Mar; 21(5):1540-51. PubMed ID: 11238891 [TBL] [Abstract][Full Text] [Related]
7. Formation of Shc/Grb2- and Crk adaptor complexes containing tyrosine phosphorylated Cbl upon stimulation of the B-cell antigen receptor. Smit L; van der Horst G; Borst J Oncogene; 1996 Jul; 13(2):381-9. PubMed ID: 8710377 [TBL] [Abstract][Full Text] [Related]
8. Dok-3 sequesters Grb2 and inhibits the Ras-Erk pathway downstream of protein-tyrosine kinases. Honma M; Higuchi O; Shirakata M; Yasuda T; Shibuya H; Iemura S; Natsume T; Yamanashi Y Genes Cells; 2006 Feb; 11(2):143-51. PubMed ID: 16436051 [TBL] [Abstract][Full Text] [Related]
9. High affinity IgG receptor activation of Src family kinases is required for modulation of the Shc-Grb2-Sos complex and the downstream activation of the nicotinamide adenine dinucleotide phosphate (reduced) oxidase. Park RK; Erdreich-Epstein A; Liu M; Izadi KD; Durden DL J Immunol; 1999 Dec; 163(11):6023-34. PubMed ID: 10570290 [TBL] [Abstract][Full Text] [Related]
10. Formation of Shc-Grb2 complexes is necessary to induce neoplastic transformation by overexpression of Shc proteins. Salcini AE; McGlade J; Pelicci G; Nicoletti I; Pawson T; Pelicci PG Oncogene; 1994 Oct; 9(10):2827-36. PubMed ID: 8084588 [TBL] [Abstract][Full Text] [Related]
11. Discrimination between phosphotyrosine-mediated signaling properties of conventional and neuronal Shc adapter molecules. Nakamura T; Komiya M; Gotoh N; Koizumi S; Shibuya M; Mori N Oncogene; 2002 Jan; 21(1):22-31. PubMed ID: 11791173 [TBL] [Abstract][Full Text] [Related]
12. Novel recruitment of Shc, Grb2, and Sos by fibroblast growth factor receptor-1 in v-Src-transformed cells. Curto M; Frankel P; Carrero A; Foster DA Biochem Biophys Res Commun; 1998 Feb; 243(2):555-60. PubMed ID: 9480847 [TBL] [Abstract][Full Text] [Related]
13. Disruption of ShcA signaling halts cell proliferation--characterization of ShcC residues that influence signaling pathways using yeast. Heinrich JN; Kwak SP; Howland DS; Chen J; Sturner S; Sullivan K; Lipinski K; Cheng KY; She Y; Lo F; Ghavami A Cell Signal; 2006 Jun; 18(6):795-806. PubMed ID: 16126371 [TBL] [Abstract][Full Text] [Related]
14. Shc adaptor proteins are key transducers of mitogenic signaling mediated by the G protein-coupled thrombin receptor. Chen Y; Grall D; Salcini AE; Pelicci PG; Pouysségur J; Van Obberghen-Schilling E EMBO J; 1996 Mar; 15(5):1037-44. PubMed ID: 8605873 [TBL] [Abstract][Full Text] [Related]
15. Tyrosine phosphorylation of Shc proteins and formation of Shc/Grb2 complex correlate to the transformation of NIH3T3 cells mediated by the point-mutation activated neu. Xie Y; Li K; Hung MC Oncogene; 1995 Jun; 10(12):2409-13. PubMed ID: 7784091 [TBL] [Abstract][Full Text] [Related]
16. Comparison of the insulin and insulin-like growth factor 1 mitogenic intracellular signaling pathways. Sasaoka T; Ishiki M; Sawa T; Ishihara H; Takata Y; Imamura T; Usui I; Olefsky JM; Kobayashi M Endocrinology; 1996 Oct; 137(10):4427-34. PubMed ID: 8828504 [TBL] [Abstract][Full Text] [Related]
17. Interleukin-6 induces tyrosine phosphorylation of the Ras activating protein Shc, and its complex formation with Grb2 in the human multiple myeloma cell line LP-1. Neumann C; Zehentmaier G; Danhauser-Riedl S; Emmerich B; Hallek M Eur J Immunol; 1996 Feb; 26(2):379-84. PubMed ID: 8617307 [TBL] [Abstract][Full Text] [Related]
18. Association of Shc, Cbl, Grb2, and Sos following treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin in primary rat hepatocytes. Park R; Kim DH; Kim MS; So HS; Chung HT; Kwon KB; Ryu DG; Kim BR Biochem Biophys Res Commun; 1998 Dec; 253(3):577-81. PubMed ID: 9918770 [TBL] [Abstract][Full Text] [Related]
19. Oncogenic Met receptor induces cell-cycle progression in Xenopus oocytes independent of direct Grb2 and Shc binding or Mos synthesis, but requires phosphatidylinositol 3-kinase and Raf signaling. Mood K; Saucier C; Ishimura A; Bong YS; Lee HS; Park M; Daar IO J Cell Physiol; 2006 Apr; 207(1):271-85. PubMed ID: 16331688 [TBL] [Abstract][Full Text] [Related]
20. Protein-tyrosine phosphatase epsilon regulates Shc signaling in a kinase-specific manner: increasing coherence in tyrosine phosphatase signaling. Kraut-Cohen J; Muller WJ; Elson A J Biol Chem; 2008 Feb; 283(8):4612-21. PubMed ID: 18093973 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]